Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaTreatment OutcomeMelphalanCombined Modality TherapyStem CellsHematologic NeoplasmsRemission InductionBone Marrow TransplantationMyeloablative AgonistsRecurrenceSalvage TherapyDisease-Free SurvivalCyclophosphamideBusulfanTransplantation ChimeraSurvival RateSurvival AnalysisHodgkin DiseaseEtoposideCytarabineHematopoietic Stem Cell MobilizationGraft SurvivalLymphoma, Non-HodgkinTissue DonorsWhole-Body IrradiationRetrospective StudiesHematopoietic Stem CellsGraft vs Leukemia EffectCarmustineVidarabineLeukemia, Myeloid, AcutePrognosisLiver TransplantationGraft vs Tumor EffectFollow-Up StudiesThiotepaHistocompatibility TestingVincristineCord Blood Stem Cell TransplantationTime FactorsNeoplasm, ResidualAntineoplastic AgentsBone Marrow PurgingImmunosuppressive AgentsAntigens, CD34Mesenchymal Stem Cell TransplantationLeukemiaMyelodysplastic SyndromesLymphocyte TransfusionDoxorubicinAntibodies, Monoclonal, Murine-DerivedLymphoma, Mantle-CellGranulocyte Colony-Stimulating FactorCell TransplantationLymphoma, FollicularAmyloidosisPrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibilitySiblingsAntineoplastic Agents, AlkylatingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphomaKidney TransplantationDexamethasoneCytomegalovirus InfectionsEmbryonic Stem CellsBoronic AcidsLymphocyte DepletionAntilymphocyte SerumPyrazinesT-LymphocytesMinor Histocompatibility AntigensHepatic Veno-Occlusive DiseaseAcute DiseaseThalidomideLeukapheresisAdult Stem CellsIfosfamideChimerismLeukemia, MyeloidVirus ActivationAutograftsChemotherapy, AdjuvantInduction ChemotherapyProspective StudiesLymphoma, T-Cell, PeripheralBlood Transfusion, AutologousHematologic DiseasesAntibodies, MonoclonalHLA AntigensFatal OutcomeTransplantation Immunology